Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Inmune Bio, Inc.

NASDAQ: INMB · Life Sciences · 4 alerts · CIK 1711754

Share price
$0.9464Close, Nov 16
Market cap
$29.3M
Shares outstanding
30.96MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Inmune Bio, Inc. filings on SEC EDGAR ↗

9:01 AM ET 8-K
Investor Presentation

Inmune Bio Investor Presentation

INmune Bio filed a formal investor presentation deck and announced a Master Services Agreement with Uniphar to establish a commercialization framework for Ebstrocel. The partnership will initially focus on named-patient access in Europe and the MENA region, providing a capital-efficient infrastructure for international distribution. Additionally, the company submitted a pre-Marketing Authorisation Application to the UK MHRA for Ebstrocel.

Counterparty
Uniphar Durbin Ireland Limited

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.